Health Care/Hospital
Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy
SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital
2020-11-10 08:15
2373
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...
2020-11-09 21:12
3652
Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020
SAN DIEGO and TAICANG, SUZHOU, China, Nov. 9, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced thatZhe...
2020-11-09 21:00
1003
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...
2020-11-09 21:00
1481
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, November 13, at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter 2020, in addition to providing a b...
2020-11-09 21:00
5237
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors
TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...
2020-11-09 20:57
1850
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit
PISCATAWAY, N.J., Nov. 9, 2020 /PRNewswire/ -- GenScript USA Inc., the world's
leading research reagent provider, announced today that the U.S. Food and Drug
Administration (FDA) has grantedEmergency Use Authorization (EUA)
2020-11-09 20:30
3531
FTLife Launches "HealthCare 168 Plus" Critical Illness Protector
HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...
2020-11-09 20:08
2514
OrbusNeich® Medical and P+F Products & Features® announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...
2020-11-09 19:00
2485
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-11-09 18:55
1993
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)
TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that they have signed an exclusive agreement with GPCR Therapeutics, Inc. ("GPCR"), a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercial...
2020-11-09 18:22
1557
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into inJuly 2019 to...
2020-11-09 18:07
1364
Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine
* Prudent approach and usability are among the top priorities * Efforts are underway to provide the best efficacy for public at large JAKARTA, Indonesia, Nov. 9, 2020 /PRNewswire/ -- In a bid to support the government's plan to develop Covid-19 vaccine inIndonesia, the National Drug and Food ...
2020-11-09 17:25
2129
SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189 in Rheumatoid Arthritis
* The Data Safety Monitoring Board (DSMB) finds no safety concerns in the 50 mg and 100 mg dose cohorts * Signs of efficacy against rheumatoid arthritis was observed. Thus, the number of patients changing from the severe to the moderate Clinical Disease Activity Index (CDAI) score was higher ...
2020-11-09 15:22
1038
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 9, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study pr...
2020-11-09 15:00
1027
For 2020, The World Innovation Summit for Health (WISH) Delivers Leading Speakers and Compelling Discussions via an Immersive Virtual Platform
DOHA, Qatar, Nov. 9, 2020 /PRNewswire/ -- The World Innovation Summit for Health (WISH) returns on15 November, 2020, offering an impressive range of speakers, networking opportunities, discussions and presentations that explore global health challenges, and – all presented through a purpose-built...
2020-11-09 09:00
2196
Ascentage Pharma to Release Updated Clinical Results of HQP1351 (Olverembatinib) in Drug-Resistant Chronic Myeloid Leukemia in an Oral Presentation at the American Society of Hematology Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Nov. 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the results from two piv...
2020-11-09 08:04
1651
Togetherall secures $10 million investment from FPE Capital
LONDON, Nov. 9, 2020 /PRNewswire/ -- Leading online mental health platform,
Togetherall
2020-11-09 08:01
2541
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), announced today that it had closed a$21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors. The Series B financing will b...
2020-11-09 08:00
1983
Large Study Shows That A Simple Blood Test Can Accurately Differentiate Between Benign and Malignant Lesions
LONDON, Nov. 9, 2020 /PRNewswire/ -- A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous growths. These...
2020-11-09 07:00
1832
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 302 media titles]
2024-04-15 17:33
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00
Most Read
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
2024-04-11 11:00
6683
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
2024-04-12 15:14
6394
XCMG Machinery Launches Premium G2 Crane Brand
2024-04-12 14:39
6329
